Locations:
Search IconSearch

Insight & Perspectives

23-NEU-4366965-CQD-Hero-650×450-1
November 20, 2023/Behavioral Health

Experts Stress Importance of Improved Access to Fentanyl Testing

Urine test strips and point-of-care testing may be key to slowing opioid epidemic

Female scientists in lab
February 23, 2023/Behavioral Health

A Proactive Approach to Dismantling Inequities for Women in Medicine

Addressing national trends of leadership inequity, burnout and lower engagement among women

23-NEU-3516858-brain-trauma-650×450

Neurotrauma Guidelines: Where They’ve Been, Where They’re Headed and How to Make the Most of Them

Q&A with Brain Trauma Foundation guideline architect Gregory Hawryluk, MD, PhD

20-NEU-2020111 neuroimmunology_650x450

Autoimmune Neurologic Disorders: Treatable Conditions That Should Not Be Missed

Q&A with newly arrived autoimmune neurology specialist Amy Kunchok, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

20-NEU-2024366_alzheimer-brain-pathology_650x450
December 9, 2020/Geriatrics

Emerging Blood-Based Biomarkers for Alzheimer Disease: A Status Report

A screening blood test would be a huge step toward earlier intervention

20-NEU-1984276 multimodal-monitoring_650x450

Multimodal Monitoring in the Neuro ICU: Essentials for Clinicians (Podcast)

A neurocritical care specialist shares what’s spurring growth of this new evaluation approach

central vein sign in multiple sclerosis

New Frontiers in Diagnosing and Monitoring Multiple Sclerosis (Podcast)

Get ready for central vein sign and optical coherence tomography

20-NEU-1938374-migraine_650x450

CGRP Antagonists for Decreasing Migraine Frequency: A Primer

How these new drugs fit into practice two years out from their first approvals

BackPage 1 of 12Next

Advertisement

Ad